Cairo – Mubasher: Minapharm Pharmaceuticals reported a decrease of 35.6% in net profits for the third quarter of 2016.
The drug firm registered net profits of EGP 24.66 million for Q3 – 2016, down from EGP 38.28 million for the same period of the previous year.
As for the first nine months of 2016, the company posted net profits of EGP 101.5 million, up from EGP 95.88 million for the same period of the previous year.
